Lpl Financial LLC Entrada Therapeutics, Inc. Transaction History
Lpl Financial LLC
- $246 Billion
- Q1 2025
A detailed history of Lpl Financial LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 11,711 shares of TRDA stock, worth $84,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,711
Previous 55,154
78.77%
Holding current value
$84,670
Previous $953,000
88.98%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TRDA
# of Institutions
111Shares Held
28.7MCall Options Held
8.2KPut Options Held
2.3K-
Baker Bros. Advisors LP New York, NY4.87MShares$35.2 Million0.52% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$31.9 Million27.61% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$31.7 Million57.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.74MShares$19.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.12MShares$15.3 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $227M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...